A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth. - Hu QY; Li L; Li YH; Zhang HB; Deng T; Liu Y; Li FT; Xiao ZX; Cao Y (Acta pharmacologica Sinica, 2025)